Continuous glucose monitoring in high-risk subjects for developing type 2 diabetes
BACKGROUND AND OBJECTIVE: To assess the relevance of unrecognised hyperglycaemia among high-risk subjects for developing type 2 diabetes.
SUBJECTS AND METHOD: Cross-sectional multicentre study in primary care. Subjects aged 40 to 75 years with previous evidence of impaired glucose metabolism were screened according to the World Health Organization rules by means of an oral glucose tolerance test (OGTT). Those with diabetes diagnostic criteria were excluded. An individualized 48-h ambulatory continuous glucose monitoring (CGM) calibrated by plasma values (Glucoday) was performed. Data from biosensor activity were computerized in order to identify hyperglycaemic records.
RESULTS: 50 out of 64 screened subjects were included and evaluated; there were 30 female (60%). Mean age was 59 years; body mass index, 30.9; HbA1c, 5.3%, and HOMA, 2.8. Regarding the CGM results, 9 whole registers (18%) were rejected because of technical problems and 41 continuous profiles (72%) were analysed, corresponding to 17 (41.5%) subjects with normal OGTT and 24 (58.5%) with non-diabetic hyperglycaemia on OGTT. Mean CGM time with hyperglycaemia (fasting > or = 6.1 mmol/l or non-fasting > or = 7.8 mmol/l) accounted for 5.8 h, a 17.2% of the effective register per subject (33.8 h). Both groups matched the World Health Organization diabetes diagnostic interval (fasting > or = 7 mmol/l or non-fasting > or = 11.1 mmol/l): 1.1 h of effective register (3.6%) and 1.2 h (3.3%), respectively.
CONCLUSIONS: The CGM evidenced a high degree of unrecognised hyperglycaemia among high-risk individuals. Therefore, casual plasma glucose measurements should be recommended to achieve early screening.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2006 |
---|---|
Erschienen: |
2006 |
Enthalten in: |
Zur Gesamtaufnahme - volume:127 |
---|---|
Enthalten in: |
Medicina clinica - 127(2006), 2 vom: 10. Juni, Seite 50-2 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
Registro continuo de glucosa en sujetos con alto riesgo de diabetes tipo 2 |
---|
Beteiligte Personen: |
Costa, Bernardo [VerfasserIn] |
---|
Themen: |
Blood Glucose |
---|
Anmerkungen: |
Date Completed 20.12.2006 Date Revised 23.08.2019 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM163756163 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM163756163 | ||
003 | DE-627 | ||
005 | 20231223101033.0 | ||
007 | tu | ||
008 | 231223s2006 xx ||||| 00| ||spa c | ||
028 | 5 | 2 | |a pubmed24n0546.xml |
035 | |a (DE-627)NLM163756163 | ||
035 | |a (NLM)16801003 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a Costa, Bernardo |e verfasserin |4 aut | |
245 | 1 | 0 | |a Continuous glucose monitoring in high-risk subjects for developing type 2 diabetes |
246 | 3 | 3 | |a Registro continuo de glucosa en sujetos con alto riesgo de diabetes tipo 2 |
264 | 1 | |c 2006 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 20.12.2006 | ||
500 | |a Date Revised 23.08.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND AND OBJECTIVE: To assess the relevance of unrecognised hyperglycaemia among high-risk subjects for developing type 2 diabetes | ||
520 | |a SUBJECTS AND METHOD: Cross-sectional multicentre study in primary care. Subjects aged 40 to 75 years with previous evidence of impaired glucose metabolism were screened according to the World Health Organization rules by means of an oral glucose tolerance test (OGTT). Those with diabetes diagnostic criteria were excluded. An individualized 48-h ambulatory continuous glucose monitoring (CGM) calibrated by plasma values (Glucoday) was performed. Data from biosensor activity were computerized in order to identify hyperglycaemic records | ||
520 | |a RESULTS: 50 out of 64 screened subjects were included and evaluated; there were 30 female (60%). Mean age was 59 years; body mass index, 30.9; HbA1c, 5.3%, and HOMA, 2.8. Regarding the CGM results, 9 whole registers (18%) were rejected because of technical problems and 41 continuous profiles (72%) were analysed, corresponding to 17 (41.5%) subjects with normal OGTT and 24 (58.5%) with non-diabetic hyperglycaemia on OGTT. Mean CGM time with hyperglycaemia (fasting > or = 6.1 mmol/l or non-fasting > or = 7.8 mmol/l) accounted for 5.8 h, a 17.2% of the effective register per subject (33.8 h). Both groups matched the World Health Organization diabetes diagnostic interval (fasting > or = 7 mmol/l or non-fasting > or = 11.1 mmol/l): 1.1 h of effective register (3.6%) and 1.2 h (3.3%), respectively | ||
520 | |a CONCLUSIONS: The CGM evidenced a high degree of unrecognised hyperglycaemia among high-risk individuals. Therefore, casual plasma glucose measurements should be recommended to achieve early screening | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 7 | |a Blood Glucose |2 NLM | |
700 | 1 | |a Vizcaíno, Jesús |e verfasserin |4 aut | |
700 | 1 | |a Cabré, Joan Josep |e verfasserin |4 aut | |
700 | 1 | |a Fuentes, Cruz María |e verfasserin |4 aut | |
700 | 1 | |a Boj, Joan |e verfasserin |4 aut | |
700 | 1 | |a Piñol, Josep Lluís |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medicina clinica |d 1948 |g 127(2006), 2 vom: 10. Juni, Seite 50-2 |w (DE-627)NLM000359017 |x 1578-8989 |7 nnns |
773 | 1 | 8 | |g volume:127 |g year:2006 |g number:2 |g day:10 |g month:06 |g pages:50-2 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 127 |j 2006 |e 2 |b 10 |c 06 |h 50-2 |